Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pennant (PNTG) Other financing activities (2018 - 2026)

Pennant posted quarterly Other financing activities of -$345000.0 for Q1 2026, up 10.85% year-on-year from -$311223.8 in Q1 2025, and up 81.78% on a QoQ basis from -$1.9 million in Q4 2025.

Pennant (PNTG) has 8 years of Other financing activities data on file, last reported at -$345000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other financing activities rose 10.85% year-over-year to -$345000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.9 million (down 103.07% YoY), and the FY2025 full-year result was -$1.9 million, down 268.48% from the prior year.
  • Other financing activities for Q1 2026 stood at -$345000.0, up from -$1.9 million in the prior quarter.
  • Across five years, Other financing activities topped out at $750000.0 in Q3 2025 and bottomed at -$1.9 million in Q4 2025.
  • The 4-year median for Other financing activities is -$218500.0 (2024), against an average of -$272000.0.
  • Peak annual rise in Other financing activities reached 1350.0% in 2025, while the deepest fall reached 3618.18% in 2025.
  • A 4-year view of Other financing activities shows it stood at $33000.0 in 2023, then tumbled by 1230.3% to -$373000.0 in 2024, then slumped by 407.77% to -$1.9 million in 2025, then surged by 81.78% to -$345000.0 in 2026.
  • The last three Other financing activities figures came in at -$345000.0 (Q1 2026), -$1.9 million (Q4 2025), and $750000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn
10 Pennant 1.19 Bn 1.23 Bn 52.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -345,000.00
Mar 31, 2026 -345,000.00
Dec 31, 2025 -1.89 Mn
Dec 31, 2025 -1.89 Mn
Sep 30, 2025 750,000.00
Sep 30, 2025 750,000.00
Jun 30, 2025 -363,000.00
Jun 30, 2025 -363,000.00
Mar 31, 2025 -387,000.00
Mar 31, 2025 -387,000.00
Dec 31, 2024 -373,000.00
Dec 31, 2024 -373,000.00
Sep 30, 2024 -60,000.00
Sep 30, 2024 -60,000.00
Jun 30, 2024 -92,000.00
Jun 30, 2024 -92,000.00
Mar 31, 2024 11,000.00
Mar 31, 2024 11,000.00
Dec 31, 2023 33,000.00
Dec 31, 2023 33,000.00
Mar 31, 2021 1.39 Mn
Mar 31, 2021 1.39 Mn
Dec 31, 2020 477,000.00
Dec 31, 2020 477,000.00
Sep 30, 2020 52,000.00
Sep 30, 2020 52,000.00
Mar 31, 2020 26,000.00
Mar 31, 2020 26,000.00
Dec 31, 2019 -2.29 Mn
Dec 31, 2019 -2.29 Mn
Sep 30, 2019 2.29 Mn
Sep 30, 2019 2.29 Mn
Dec 31, 2018 -1.97 Mn
Dec 31, 2018 -1.97 Mn